Work

A phase 1b multitumor cohort study of cabozantinib plus atezolizumab in advanced solid tumors (COSMIC-021): Results of the colorectal cancer cohort.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.4_suppl.121

Authors: Thomas Adam Abrams, Syed Mohammad Ali Kazmi, Ira Seth Winer, Vivek Subbiah, Gerald Steven Falchook, Matthew Reilley, Paul Raymond Kunk, Sanjay Goel, Ignacio Garrido-Laguna, Mark D. Kochenderfer, Scott Werneke, Lana Andrianova, Ramu Sudhagoni, Scott Paulson

Institutions: Dana-Farber Cancer Institute, The University of Texas Southwestern Medical Center, Wayne State University, The Barbara Ann Karmanos Cancer Institute, The University of Texas MD Anderson Cancer Center, University of Virginia Health System, Montefiore Medical Center, University of Utah, Huntsman Cancer Institute, Exelixis (United States)

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Exelixis

OpenAlex ID: W4206337677

Cites:

Cited by: 21

Related to: 10